Vascular Access Device Market by Type (Peripheral (Midline, Short), Central (PICC, Tunneled, Non-Tunneled, Implanted Ports), Accessories), Application (Drug Administration, Fluid & Nutrition Administration) & End Users - & Geography
The global vascular access devices market is projected to grow at a CAGR of 7.1%. Vascular access devices include central vascular access devices, peripheral vascular access devices, and accessories. Base year considered for the report is 2016. The key factors driving the growth of this market include the growing prevalence of lifestyle diseases, an increase in the number of chemotherapy procedures and the increasing use of vascular access devices in pediatric patients.
Objectives of the Study
- To define, describe, and forecast the vascular access devices market by type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)
- To profile the key players and analyze their market shares and core competencies
- To track and analyze competitive developments such as product launches, approval, agreements, collaborations, and acquisitions in the global market
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of other dependent submarkets. Various secondary sources such as associations World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Association of Percutaneous Cardiovascular Interventions (EAPCI) directories, Society for Cardiac Angiography and Interventions (SCAI), industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study ofthis market. Primary sources such as experts from both supply and demand sides have been interviewed to obtainand validateinformation as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:
To know about the assumptions considered for the study, download the pdf brochure
The major players in the global vascular access device market are Becton, Dickinson and Company (U.S.), C. R. Bard, Inc. (U.S.), Smiths Medical, Inc. (U.K.), Teleflex Incorporated (U.S.), B.Braun Melsungen AG (Germany), NIPRO Medical Corporation (Japan), Edwards Lifesciences Corporation (U.S.), Terumo Corporation (Japan), Vygon Ltd. (U.K.), Ameco Medical (Egypt), AngioDynamics (U.S.), Romsons Scientific & Surgical Pvt. Ltd. (India), and PRODIMED (France).
Target Audience:
- Vascular access device manufacturers and distributors
- Interventional cardiology vascular device manufacturers
- Research and consulting firms
- Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and governing bodies)
- Research institutes
- Vendors/service providers
- Niche companies manufacturing novel vascular access devices
- Research and consulting firms
Get online access to the report on the World's First Market Intelligence Cloud
Request Sample Scope of the Report
:
The research report categorizes the global market into the following segments and subsegments:
By Type
-
Central Vascular Access Devices
- Peripherally inserted central catheters (PICC)
- Tunneled catheters
- Non tunneled catheters
- Implanted ports
-
Peripheral Vascular Access Devices
- Midline catheter (short) devices
- Midclavicular catheter (Midline) devices
- Winged steel needles
- Accessories
By Application
- Drug administration
- Fluid and nutrition administration
- Blood transfusion
- Diagnostics & testing
By End User
- Hospitals
- Clinics and ambulatory care centers
- Other end users
By Geography
-
North America
- U.S.
- Canada
-
Europe
- U.K.
- Germany
- France
- Rest of Europe (RoE)
- Asia-Pacific
-
Rest of the World (RoW)
- Japan
-
RoW
- Latin America
- Middle East & Africa
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the rest of Europe segment into France, Finland, Sweden, and Switzerland
Company Information
- Detailed analysis and profiling of additional market players (Up to 5)
The global vascular access device market is expected to reach USD 5.45 Billion by 2022 from USD 3.87 Billion in 2017, at a CAGR of 7.1%. The major drivers for the market include the growing prevalence of lifestyle diseases, an increase in the number of chemotherapy procedures and the increasing use of vascular access devices in pediatric patients.
The report analyzes the market by type, application, end user, and region. The type segment includes central vascular access devices, peripheral vascular access devices, and accessories. The central vascular access devices segment is expected to account for the largest share of the vascular access devices market in 2017. The dominant share of the market is attributed to the fact that central vascular access devices are used in chemotherapy and for the treatment of cardiovascular disorders and chronic kidney disorders.
Based on application, the market is broadly classified into drug administration, fluids and nutrition administration, blood transfusion, and diagnostics and testing. The drug administration segment is estimated to account for the largest share of the market in 2017, the growth of drug administration segment is attributed to the high usage of vascular access devices for drug administration for the treatment of infections, cancer, and other diseases.
The end user segment of the market includes hospitals, clinics and ambulatory care centers, and other end users. In 2017, the hospital segment is expected to dominate this market. The large share of this segment can be attributed to the fact that a majority of vascular procedures are performed in hospital settings.
The geographic segments in this report include North America, Europe, Asia-Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. The large share of this segment can primarily be attributed to the high prevalence of cardiovascular diseases in the U.S.; an increase in the number of cancer cases; and an increase in research and clinical trials for vascular access devices.
The major players in this market include Major players include Becton Dickinson and Company (U.S.), Smiths Medical, Inc. (U.K.), and C.R.Bard, Inc. (U.S.). Other players include Teleflex Incorporated (U.S.) B.Braun Melsungen Ag (Germany), Angiodynamics (U.S.), Terumo Corporation (Japan), Nipro Medical Corporation, Edwards Lifesciences Corporation (U.S.), Ameco Medical (Egypt), Romsons Scientific & Surgical Pvt. Ltd (India), and Prodi med (France).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 17)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Insights From Primary Sources
2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Forecast Methodology
2.5 Market Data Validation and Triangulation
2.6 Assumptions of the Study
3 Executive Summary (Page No. - 27)
4 Premium Insights (Page No. - 31)
4.1 Vascular Access Devices: Market Overview (2017-2022)
4.2 Vascular Access Devices Market, By Type (2017)
4.3 Vascular Access Device Market, By Application, 2017 vs 2022
4.4 Vascular Access Devices Market, By End User, 2017 vs 2022
4.5 Geographic Snapshot of the Global Market
5 Market Overview (Page No. - 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Prevalence of Lifestyle Diseases
5.2.1.2 Increasing Number of Chemotherapy Procedures
5.2.1.3 Increasing Use of Vascular Access Devices in Pediatric Patients
5.2.2 Restraints
5.2.2.1 High Costs Involved in the Placement and Maintenance of Vascular Access Devices
5.2.2.2 Product Recalls and Failures
5.2.3 Opportunity
5.2.3.1 Technological Advancements
5.2.4 Challenges
5.2.4.1 Shortage of Skilled Professionals
5.2.4.2 Risks Associated With Vascular Access Devices
6 Global Vascular Access Device Market, By Type (Page No. - 41)
6.1 Introduction
6.2 Central Vascular Access Devices
6.2.1 Peripherally Inserted Central Catheters
6.2.2 Tunneled Catheters
6.2.3 Non-Tunneled Catheters
6.2.4 Implanted Ports
6.3 Peripheral Vascular Access Devices
6.3.1 Peripheral Short Devices
6.3.2 Peripheral Midline Devices
6.3.3 Butterfly/Winged Steel Needles
6.4 Accessories
7 Global Vascular Access Device Market, By Application (Page No. - 52)
7.1 Introduction
7.2 Drug Administration
7.3 Fluid and Nutrition Administration
7.4 Blood Transfusion
7.5 Diagnostics and Testing
8 Global Vascular Access Device Market, By End User (Page No. - 57)
8.1 Introduction
8.2 Hospitals
8.3 Clinics and Ambulatory Care Centers
8.4 Other End Users
9 Vascular Access Device Market, By Region (Page No. - 61)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.1.1 Rising Prevalence of Cvd
9.2.1.2 Increasing Number of Cancer Cases
9.2.1.3 Increase in Research and Clinical Trials for Vascular Access Devices
9.2.1.4 Conferences, Meetings, Symposia, and Workshops
9.2.2 Canada
9.2.2.1 Increasing Number of Cardiac Arrest Cases
9.2.2.2 Increase in Cancer Incidence
9.2.2.3 Increasing Number of Minimally Invasive Procedures
9.3 Europe
9.3.1 Increasing Focus of Market Players on Europe
9.3.2 New Rules and Regulations for Medical Devices
9.3.3 Rising Geriatric Population
9.3.4 E-3
9.3.4.1 Rising Prevalence of Cvd in U.K. and Germany
9.3.4.2 Growing Prevalence of Cancer in Eu-3
9.3.4.3 Increasing Prevalence of Lifestyle Diseases in the U.K.
9.3.4.4 Favorable Government Support, Growth in Aging Population in France
9.3.4.5 Prevalence of Esrd and Need for Dialysis Treatment
9.3.5 RoE
9.3.5.1 Improving Healthcare Structure in Russia
9.3.5.2 Turkey: Growth in the Healthcare Sector, Rising Medical Tourism
9.4 Asia-Pacific
9.4.1 Increasing Chronic Kidney Disease Prevalence in Japan
9.4.2 Japan & China: Rapid Growth in Geriatric Population
9.4.3 Healthcare Reforms, Government Initiatives, and Investments in China and Japan
9.5 Rest of the World
9.5.1 Prevalence of Ckd and Government Initiatives in the RoW
9.5.2 Middle East: Increasing Geriatric Population, Rise in Age-Related Disorders
9.5.3 Growing Medical Tourism in the RoW
9.5.4 High Prevalence of Obesity in Latin America
10 Competitive Landscape (Page No. - 92)
10.1 Overview
10.2 Market Share Analysis
10.3 Market Ranking (As of 2016)
10.3.1 Vendor Inclusion Criteria
10.4 Competitive Leadership Mapping (2017)
10.4.1 Visionary Leaders
10.4.2 Innovators
10.4.3 Dynamic Differentiators
10.4.4 Emerging Companies
10.5 Competitive Benchmarking
10.5.1 Strength of Product Portfolio
10.5.2 Business Strategy Excellence
*Top 25 Companies Analyzed for This Studies are - Smiths Medical (U.S.), Terumo Medical Corporation (Japan), Becton Dickinson and Company (U.S.), Teleflex Incorporated (U.S.), C.R.Bard, Inc. (U.S.), B Braun Melsungen Ag. (Germany), Nipro Medical Corporation (Japan), Vygon Ltd. (U.K.), Ameco Medical (Egypt), Romson Scientific (India), Prodimed (France), Edward Lifescience Corporation LLC (U.S.), Angiodynamics (U.S.), Biosensors International Group, Ltd (Singapore), Centurion Medical Products (U.S.), Fresenius Medical Care Asia Pacific Limited (Hong Kong), Access Scientific, LLC (U.S.), 3M. (U.S.), Zoll Medical Corporation (U.S.), Medtronic PLC (Ireland), Baxter International Inc. (U.S.), Merit Medical System, Inc. (U.S.), Hospira (U.S.), Bionic Medizintechnik GmbH (Germany), Medical Components, Inc. (U.S)
11 Company Profiles (Page No. - 97)
(Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments)*
11.1 Becton, Dickinson and Company
11.2 C.R.Bard, Inc.
11.3 Teleflex Incorporated
11.4 Smiths Medical, Inc.
11.5 B Braun Melsungen AG
11.6 Angiodynamics (Navilyst Medical, Inc)
11.7 Terumo Corporation
11.8 Nipro Medical Corporation
11.9 Edwards Lifesciences Corporation
11.10 Ameco Medical
11.11 Romsons Scientific & Surgical Pvt. Ltd.
11.12 Prodimed
*Details on Marketsandmarkets View, Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. - 130)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details
List of Tables (69 Tables)
Table 1 Global Vascular Access Devices Market, By Type, 2015–2022 (USD Million)
Table 2 Global Central Market, By Type, 2015–2022 (USD Million)
Table 3 Central Vascular Access Device Market, By Region, 2015–2022 (USD Million)
Table 4 Peripherally Inserted Central Catheters Market, By Region, 2015–2022 (USD Million)
Table 5 Tunneled Catheters Market, By Region, 2015–2022 (USD Million)
Table 6 Non-Tunneled Catheters Market, By Region, 2015–2022 (USD Million)
Table 7 Implanted Ports Market, By Region, 2015–2022 (USD Million)
Table 8 Global Peripheral Market, By Type, 2015–2022 (USD Million)
Table 9 Peripheral Market Size, By Region, 2015–2022 (USD Million)
Table 10 Peripheral Short Devices Market Size, By Region, 2015–2022 (USD Million)
Table 11 Peripheral Midline Devices Market, By Region, 2015–2022 (USD Million)
Table 12 Butterfly/Winged Steel Needles Market Size, By Region, 2015–2022 (USD Million)
Table 13 Global Market for Accessories, By Region, 2015–2022 (USD Million)
Table 14 Market, By Application, 2015–2022 (USD Million)
Table 15 Market for Drug Administration, By Region, 2015–2022 (USD Million)
Table 16 Vascular Access Devices Market for Fluid and Nutrition Administration, By Region, 2015–2022 (USD Million)
Table 17 Global Market for Blood Transfusion, By Region, 2015–2022 (USD Million)
Table 18 Global Market for Diagnostics and Testing, By Region, 2015–2022 (USD Million)
Table 19 Global Market, By End User, 2015–2022 (USD Million)
Table 20 Global Market for Hospitals, By Region, 2015–2022 (USD Million)
Table 21 Market Size for Clinics and Ambulatory Care Centers, By Region, 2015–2022 (USD Million)
Table 22 Vascular Access Devices Market for Other End Users, By Region, 2015–2022 (USD Million)
Table 23 Market, By Region, 2015-2022 (USD Million)
Table 24 North America: Market, By Country, 2015-2022 (USD Million)
Table 25 North America: Market, By Type, 2015-2022 (USD Million)
Table 26 North America: Peripheral Vascular Access Devices Market, By Type, 2015-2022 (USD Million)
Table 27 North America: Central Vascular Access Device Market, By Type, 2015-2022 (USD Million)
Table 28 North America: Market, By Application, 2015-2022 (USD Million)
Table 29 North America: Market, By End User, 2015-2022 (USD Million)
Table 30 Indicative List of Clinical Trials Conducted
Table 31 Indicative List of Recent Events in the U.S.
Table 32 U.S.: Market, By Type, 2015-2022 (USD Million)
Table 33 U.S.: Peripheral Vascular Access Device Market, By Type, 2015-2022 (USD Million)
Table 34 U.S.: Central Vascular Access Devices Market, By Type, 2015-2022 (USD Million)
Table 35 U.S.: Market, By Application, 2015-2022 (USD Million)
Table 36 U.S.: Market, By End User, 2015-2022 (USD Million)
Table 37 Canada: Market, By Type, 2015-2022 (USD Million)
Table 38 Canada: Peripheral Vascular Access Device Market, By Type, 2015-2022 (USD Million)
Table 39 Canada: Central Vascular Access Devices Market, By Type, 2015-2022 (USD Million)
Table 40 Canada: Market, By Application, 2015-2022 (USD Million)
Table 41 Canada: Market, By End User, 2015-2022 (USD Million)
Table 42 Geriatric Population in European Countries (As A Percentage of the Total)
Table 43 Europe: Market, By Region, 2015-2022 (USD Million)
Table 44 Europe: Market, By Type, 2015-2022 (USD Million)
Table 45 Europe: Peripheral Vascular Access Device Market, By Type, 2015-2022 (USD Million)
Table 46 Europe: Central Vascular Access Devices Market, By Type, 2015-2022 (USD Million)
Table 47 Europe: Market, By Application, 2015-2022 (USD Million)
Table 48 Europe: Market, By End User, 2015-2022 (USD Million)
Table 49 E-3: Market, By Type, 2015-2022 (USD Million)
Table 50 E-3: Peripheral Vascular Access Devices Market, By Type, 2015-2022 (USD Million)
Table 51 E-3: Central Vascular Access Device Market, By Type, 2015-2022 (USD Million)
Table 52 E-3: Market, By Application, 2015-2022 (USD Million)
Table 53 E-3: Market, By End User, 2015-2022 (USD Million)
Table 54 RoE: Market, By Type, 2015-2022 (USD Million)
Table 55 RoE: Peripheral Vascular Access Devices Market, By Type, 2015-2022 (USD Million)
Table 56 RoE: Central Vascular Access Device Market, By Type, 2015-2022 (USD Million)
Table 57 RoE: Market, By Application, 2015-2022 (USD Million)
Table 58 RoE: Market, By End User, 2015-2022 (USD Million)
Table 59 Asia-Pacific: Market, By Type, 2015-2022 (USD Million)
Table 60 Asia-Pacific: Peripheral Vascular Access Devices Market, By Type, 2015-2022 (USD Million)
Table 61 Asia -Pacific: Central Vascular Access Device Market, By Type, 2015-2022 (USD Million)
Table 62 Asia-Pacific: Market, By Application, 2015-2022 (USD Million)
Table 63 Asia-Pacific: Market, By End User, 2015-2022 (USD Million)
Table 64 Percentage of Obese Population in Latin American Countries
Table 65 RoW: Market, By Type, 2015-2022 (USD Million)
Table 66 RoW: Peripheral Vascular Access Devices Market, By Type, 2015-2022 (USD Million)
Table 67 RoW: Central Vascular Access Device Market, By Type, 2015-2022 (USD Million)
Table 68 RoW: Vascular Access Devices Market, By Application, 2015-2022 (USD Million)
Table 69 RoW: Market, By End User, 2015-2022 (USD Million)
List of Figures (40 Figures)
Figure 1 Research Methodology: Global Vascular Access Devices
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Sampling Frame: Primary Research
Figure 4 Key Data From Primary Sources
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Research Design: Global Vascular Access Devices
Figure 8 Data Triangulation Methodology
Figure 9 Global Market, By Type (2017)
Figure 10 Global Market, By Application, 2017 vs 2022 (USD Million)
Figure 11 Global Market, By End User, 2017 vs 2022 (USD Million)
Figure 12 Geographical Snapshot of the Global Market
Figure 13 Rising Prevalence of Lifestyle Diseases is the Major Factor Driving the Growth of the Vascular Access Devices Market
Figure 14 Central Venous Access Devices Segment to Account for the Largest Market Share in 2017
Figure 15 Drug Administration Segment Will Continue to Dominate the Market During the Forecast Period
Figure 16 Hospitals Segment to Account for the Largest Market Share in 2017
Figure 17 APAC to Register the Highest CAGR in the Forecast Period
Figure 18 Global Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Central Vascular Access Devices to Command the Largest Share of the Global Market in 2017
Figure 20 Peripherally Inserted Central Catheters to Command the Largest Share of the Global Central Market in 2017
Figure 21 Peripheral Short Devices to Command the Largest Share of the Global Peripheral Vascular Access Devices Market in 2017
Figure 22 Drug Administration to Form the Largest End-User Segment in the Global Market in 2017
Figure 23 Hospitals to Form the Largest End-User Segment in the Market in 2017
Figure 24 North America to Dominate the Market in 2017
Figure 25 North America: Vascular Access Devices Market Snapshot
Figure 26 Europe: Vascular Access Devices Snapshot
Figure 27 Cancer Incidence in Eu-3
Figure 28 Asia-Pacific: Market Snapshot
Figure 29 RoW: Market Snapshot
Figure 30 Global Market Share Analysis, By Key Player (2016)
Figure 31 Competitive Leadership Mapping: Market
Figure 32 Becton, Dickinson and Company: Company Snapshot (2016)
Figure 33 C.R.Bard Inc. Company Snapshot (2016)
Figure 34 Teleflex Incorporated. Company Snapshot (2016)
Figure 35 Smiths Medical Inc.: Company Snapshot (2016)
Figure 36 B Braun Melsungen AG Company Snapshot (2016)
Figure 37 Angiodynamics Company Snapshot (2016)
Figure 38 Terumo Corporation: Company Snapshot (2016)
Figure 39 Nipro Medical Corporation Company Snapshot (2016)
Figure 40 Edwards Lifesciences Corporation Company Snapshot (2016)
Generating Response ...
Growth opportunities and latent adjacency in Vascular Access Device Market